MET233 Research Site 001 — Cypress, California

MET233 Research Site 001 is a clinical research site located in Cypress, California, United States 90630.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

MET233 Research Site 001 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Obesity and Overweight.

Sponsors: Metsera, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MET233 Research Site 001?

MET233 Research Site 001 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MET233 Research Site 001 conducted?

MET233 Research Site 001 has 1 clinical trials on record, with 1 currently active. Their work covers Obesity and Overweight.

Is MET233 Research Site 001 accredited by Crixeo Health?

MET233 Research Site 001 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MET233 Research Site 001?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.